Acadia Healthcare Company, Inc. (ACHC)
USD 23.31
(2.33%)
USD 23.31
(2.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.35 Billion USD | 7.44% |
| 2022 | 4.98 Billion USD | 4.61% |
| 2021 | 4.76 Billion USD | -26.64% |
| 2020 | 6.49 Billion USD | -5.52% |
| 2019 | 6.87 Billion USD | 11.45% |
| 2018 | 6.17 Billion USD | -3.92% |
| 2017 | 6.42 Billion USD | 6.64% |
| 2016 | 6.02 Billion USD | 40.56% |
| 2015 | 4.28 Billion USD | 92.76% |
| 2014 | 2.22 Billion USD | 81.57% |
| 2013 | 1.22 Billion USD | 24.53% |
| 2012 | 983.41 Million USD | 138.12% |
| 2011 | 412.99 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.67 Billion USD | 2.91% |
| 2024 Q1 | 5.51 Billion USD | 2.96% |
| 2024 Q3 | 5.87 Billion USD | 3.39% |
| 2023 Q3 | 5.34 Billion USD | 3.81% |
| 2023 FY | 5.35 Billion USD | 7.44% |
| 2023 Q1 | 5.04 Billion USD | 1.13% |
| 2023 Q4 | 5.35 Billion USD | 0.24% |
| 2023 Q2 | 5.15 Billion USD | 2.1% |
| 2022 FY | 4.98 Billion USD | 4.61% |
| 2022 Q4 | 4.98 Billion USD | 0.91% |
| 2022 Q3 | 4.94 Billion USD | 1.24% |
| 2022 Q2 | 4.88 Billion USD | 0.99% |
| 2022 Q1 | 4.83 Billion USD | 1.4% |
| 2021 Q2 | 4.56 Billion USD | 0.82% |
| 2021 FY | 4.76 Billion USD | -26.64% |
| 2021 Q1 | 4.52 Billion USD | -30.35% |
| 2021 Q3 | 4.59 Billion USD | 0.67% |
| 2021 Q4 | 4.76 Billion USD | 3.77% |
| 2020 FY | 6.49 Billion USD | -5.52% |
| 2020 Q1 | 6.71 Billion USD | -2.34% |
| 2020 Q3 | 7.1 Billion USD | 3.98% |
| 2020 Q4 | 6.49 Billion USD | -8.53% |
| 2020 Q2 | 6.83 Billion USD | 1.72% |
| 2019 Q3 | 6.72 Billion USD | -0.92% |
| 2019 FY | 6.87 Billion USD | 11.45% |
| 2019 Q1 | 6.78 Billion USD | 9.93% |
| 2019 Q2 | 6.79 Billion USD | 0.07% |
| 2019 Q4 | 6.87 Billion USD | 2.24% |
| 2018 Q2 | 6.5 Billion USD | -1.24% |
| 2018 FY | 6.17 Billion USD | -3.92% |
| 2018 Q3 | 6.52 Billion USD | 0.41% |
| 2018 Q1 | 6.58 Billion USD | 2.49% |
| 2018 Q4 | 6.17 Billion USD | -5.47% |
| 2017 Q2 | 6.22 Billion USD | 2.67% |
| 2017 Q1 | 6.06 Billion USD | 0.68% |
| 2017 Q4 | 6.42 Billion USD | 1.29% |
| 2017 FY | 6.42 Billion USD | 6.64% |
| 2017 Q3 | 6.34 Billion USD | 1.84% |
| 2016 Q3 | 6.45 Billion USD | -3.46% |
| 2016 Q1 | 6.69 Billion USD | 56.23% |
| 2016 FY | 6.02 Billion USD | 40.56% |
| 2016 Q4 | 6.02 Billion USD | -6.64% |
| 2016 Q2 | 6.68 Billion USD | -0.18% |
| 2015 Q1 | 3.62 Billion USD | 63.12% |
| 2015 Q4 | 4.28 Billion USD | 3.4% |
| 2015 Q3 | 4.14 Billion USD | 5.57% |
| 2015 Q2 | 3.92 Billion USD | 8.25% |
| 2015 FY | 4.28 Billion USD | 92.76% |
| 2014 Q3 | 2.14 Billion USD | 34.4% |
| 2014 Q2 | 1.59 Billion USD | 24.13% |
| 2014 Q1 | 1.28 Billion USD | 4.76% |
| 2014 FY | 2.22 Billion USD | 81.57% |
| 2014 Q4 | 2.22 Billion USD | 3.88% |
| 2013 FY | 1.22 Billion USD | 24.53% |
| 2013 Q2 | 1.11 Billion USD | 2.67% |
| 2013 Q3 | 1.16 Billion USD | 4.38% |
| 2013 Q4 | 1.22 Billion USD | 5.3% |
| 2013 Q1 | 1.08 Billion USD | 10.35% |
| 2012 Q4 | 983.41 Million USD | 62.88% |
| 2012 FY | 983.41 Million USD | 138.12% |
| 2012 Q3 | 603.75 Million USD | 2.95% |
| 2012 Q2 | 586.45 Million USD | 29.39% |
| 2012 Q1 | 453.25 Million USD | 9.75% |
| 2011 Q3 | 269.6 Million USD | 0.0% |
| 2011 Q4 | 412.99 Million USD | 53.18% |
| 2011 FY | 412.99 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Addus HomeCare Corporation | 1.02 Billion USD | -423.107% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -2409.385% |
| Amedisys, Inc. | 2.06 Billion USD | -160.116% |
| Astrana Health, Inc. | 933.36 Million USD | -474.145% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | -227.325% |
| IMAC Holdings, Inc. | 1.14 Million USD | -468281.436% |
| biote Corp. | 155.29 Million USD | -3350.749% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -8653.305% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | -688.857% |
| COMPASS Pathways plc | 275.98 Million USD | -1841.701% |
| DocGo Inc. | 490.45 Million USD | -992.633% |
| The Ensign Group, Inc. | 4.17 Billion USD | -28.277% |
| Healthcare Services Group, Inc. | 803.18 Million USD | -567.201% |
| InnovAge Holding Corp. | 547.66 Million USD | -878.496% |
| The Joint Corp. | 87.15 Million USD | -6048.925% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | -139.962% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -67301.591% |
| ModivCare Inc. | 1.76 Billion USD | -203.226% |
| NewGenIvf Group Limited | 1.64 Million USD | -325178.975% |
| Option Care Health, Inc. | 3.32 Billion USD | -61.006% |
| P3 Health Partners Inc. | 860.96 Million USD | -522.421% |
| P3 Health Partners Inc. | 860.96 Million USD | -522.421% |
| The Pennant Group, Inc. | 539.69 Million USD | -892.946% |
| Surgery Partners, Inc. | 7.01 Billion USD | 23.653% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -108746.902% |
| Talkspace, Inc. | 142.22 Million USD | -3667.967% |
| Talkspace, Inc. | 142.22 Million USD | -3667.967% |
| The Oncology Institute, Inc. | 219.41 Million USD | -2342.298% |
| The Oncology Institute, Inc. | 219.41 Million USD | -2342.298% |